Euroapi S.A. ( EAPIF) - Key Metrics
EAPIF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.76 | -$1.49 | -$0.69 | -$1.10 |
| 2025Q4 | $4.60 | -$1.93 | $1.14 | $0.71 |
| 2025Q2 | $4.38 | -$0.30 | $0.19 | -$0.21 |
| 2024Q4 | $4.96 | -$1.01 | $0.55 | $0.05 |
| 2024Q2 | $4.79 | -$0.37 | $0.76 | $0.11 |
EAPIF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.22 |
| 2025Q4 | 0% | -0.29 |
| 2025Q2 | 0% | -2.19 |
| 2024Q4 | 0% | -0.72 |
| 2024Q2 | 0% | -1.78 |
EAPIF
Price: $0.84
52 week price:
Earnings Per Share: -2.56 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 80.7 million